U.S. Hemostats Market Size, Share & Industry Analysis, By Product (Active Hemostats [Thrombin-based Hemostats, and Fibrin Sealants], Passive Hemostats [Plant-based, Animal-based, and Others], Combination Hemostats, and Others), By Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, and Others), By End-user (Hospitals & ASCs, Tactical Combat Casualty Care Centers, and Others), and Country Forecast, 2025-2032

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI108837

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Number of Key Surgical Procedures in the U.S., 2024
2. Epidemiology of Key Diseases in the U.S., 2024
3. New Product Launches, By Key Players
4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
5. Impact of COVID-19 on the Market
U.S. Hemostats Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Active Hemostats
    1. Thrombin-based Hemostats
    2. Fibrin Sealants
  2. Passive Hemostats
    1. Plant-based
    2. Animal-based
    3. Others
  3. Combination Hemostats
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Trauma
  2. Cardiovascular Surgery
  3. General Surgery
  4. Plastic Surgery
  5. Orthopedic Surgery
  6. Neurosurgery
  7. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & ASCs
  2. Tactical Combat Casualty Care Centers
  3. Others
Competitive Analysis
1. U.S. Market Share Analysis (2024)
2. Company Profiles
  1. Pfizer Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  2. Johnson & Johnson Services, Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  3. Integra LifeSciences Corporation
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  4. Medtronic
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  5. BD
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  6. Stryker
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  7. Baxter
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  8. Artivion, Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  9. Aegis Lifesciences Private Limited
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Number of Key Surgical Procedures in the U.S., 2024
2. Epidemiology of Key Diseases in the U.S., 2024
3. New Product Launches, By Key Players
4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
5. Impact of COVID-19 on the Market
U.S. Hemostats Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Active Hemostats
    1. Thrombin-based Hemostats
    2. Fibrin Sealants
  2. Passive Hemostats
    1. Plant-based
    2. Animal-based
    3. Others
  3. Combination Hemostats
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Trauma
  2. Cardiovascular Surgery
  3. General Surgery
  4. Plastic Surgery
  5. Orthopedic Surgery
  6. Neurosurgery
  7. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & ASCs
  2. Tactical Combat Casualty Care Centers
  3. Others
Competitive Analysis
1. U.S. Market Share Analysis (2024)
2. Company Profiles
  1. Pfizer Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  2. Johnson & Johnson Services, Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  3. Integra LifeSciences Corporation
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  4. Medtronic
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  5. BD
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  6. Stryker
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  7. Baxter
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  8. Artivion, Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  9. Aegis Lifesciences Private Limited
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.

Read Less

List of Figures

Figure 1: U.S. Hemostats Market Revenue Breakdown (USD billion, %) by Product, 2024 & 2032

Figure 2: U.S. Hemostats Market Value Share (%), by Product, 2024 & 2032

Figure 3: U.S. Hemostats Market Value Share (%), by Application, 2024 & 2032

Figure 4: U.S. Hemostats Market Value Share (%), by End-user, 2024 & 2032

Figure 5: U.S. Hemostats Market Share (%), By Company, 2024

List of Tables

Table 1: U.S. Hemostats Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 2: U.S. Hemostats Market Revenue (USD billion) Forecast, by Active Hemostats, 2019–2032

Table 3: U.S. Hemostats Market Revenue (USD billion) Forecast, by Passive Hemostats, 2019–2032

Table 4: U.S. Hemostats Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 5: U.S. Hemostats Market Revenue (USD billion) Forecast, by End-user 2019–2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 96

(Offer valid till 31^st Dec 2025)

Download Free Sample

Security Code

Growth Advisory Services

How can we help you uncover new opportunities and scale faster?

Clients

Related Reports

Antithrombin Market

Biodegradable Hemostat Market

Thrombin Market

Prothrombin Complex Concentrate PCC Market

hemostats market

Hemophilia Drugs Market

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)

sales@fortunebusinessinsights.com